articleNature BiotechnologyJul 29, 2007Closed access

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells

FSFarbod ShojaeiXWXiumin WuAKAjay K. MalikCZCuiling ZhongMEMegan E. Baldwin

Seagen (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

840
total citations
FWCI
22.99
Percentile
100%
References
52
Citations per year

Authors

9

Topics & keywords

Topics
Keywords
  • Integrin alpha M
  • Cancer research
  • Myeloid
  • Bone marrow
  • Vascular endothelial growth factor
  • Biology
  • Monoclonal antibody
  • Myeloid leukemia
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.